197 related articles for article (PubMed ID: 25623898)
1. Conventional markers in determination of activity of sarcoidosis.
Gungor S; Ozseker F; Yalcinsoy M; Akkaya E; Can G; Eroglu H; Genc NS
Int Immunopharmacol; 2015 Mar; 25(1):174-9. PubMed ID: 25623898
[TBL] [Abstract][Full Text] [Related]
2. YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity.
Uysal P; Durmus S; Sozer V; Gelisgen R; Seyhan EC; Erdenen F; Simsek G; Uzun H
Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30154391
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis.
Gundlach E; Hoffmann MM; Prasse A; Heinzelmann S; Ness T
PLoS One; 2016; 11(1):e0147258. PubMed ID: 26799486
[TBL] [Abstract][Full Text] [Related]
4. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis.
Rothkrantz-Kos S; van Dieijen-Visser MP; Mulder PG; Drent M
Clin Chem; 2003 Sep; 49(9):1510-7. PubMed ID: 12928233
[TBL] [Abstract][Full Text] [Related]
5. [Serum adenosine deaminase as a parameter for activity in sarcoidosis].
Wetzel E; Müller-Quernheim J; Lorenz J
Pneumologie; 1999 Jul; 53(7):323-8. PubMed ID: 10444948
[TBL] [Abstract][Full Text] [Related]
6. Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement.
Thi Hong Nguyen C; Kambe N; Kishimoto I; Ueda-Hayakawa I; Okamoto H
J Dermatol; 2017 Jul; 44(7):789-797. PubMed ID: 28295528
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.
Groen-Hakan F; Eurelings L; ten Berge JC; van Laar J; Ramakers CRB; Dik WA; Rothova A
JAMA Ophthalmol; 2017 Dec; 135(12):1352-1358. PubMed ID: 29121154
[TBL] [Abstract][Full Text] [Related]
8. [Serum adenosine deaminase and angiotensin converting enzyme activity in patients with endogenous uveitis].
Fukami R; Ohba S; Ishida K; Nakamura S; Konno M; Ohno S
Nippon Ganka Gakkai Zasshi; 1994 Mar; 98(3):287-92. PubMed ID: 8154388
[TBL] [Abstract][Full Text] [Related]
9. ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy.
Vorselaars AD; van Moorsel CH; Zanen P; Ruven HJ; Claessen AM; van Velzen-Blad H; Grutters JC
Respir Med; 2015 Feb; 109(2):279-85. PubMed ID: 25496652
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis.
Eurelings LEM; Miedema JR; Dalm VASH; van Daele PLA; van Hagen PM; van Laar JAM; Dik WA
PLoS One; 2019; 14(10):e0223897. PubMed ID: 31622413
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of serum markers in pulmonary sarcoidosis.
Miyoshi S; Hamada H; Kadowaki T; Hamaguchi N; Ito R; Irifune K; Higaki J
Chest; 2010 Jun; 137(6):1391-7. PubMed ID: 20081103
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin-2 receptor in exhaled breath condensate in pulmonary sarcoidosis: a cross-sectional pilot study.
Terrington DL; Kim JW; Ravenhill G; Tang J; Piec I; Fowler SJ; Fraser W; Wilson AM
J Breath Res; 2020 Dec; 15(1):016016. PubMed ID: 33336649
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting Enzyme as a Predictor of Extrathoracic Involvement of Sarcoidosis.
Yasar Z; Özgül MA; Cetinkaya E; Kargi A; Gül Ş; Talay F; Tanriverdi E; Dincer HE
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan; 32(4):318-24. PubMed ID: 26847099
[TBL] [Abstract][Full Text] [Related]
14. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers.
Ziegenhagen MW; Benner UK; Zissel G; Zabel P; Schlaak M; Müller-Quernheim J
Am J Respir Crit Care Med; 1997 Nov; 156(5):1586-92. PubMed ID: 9372680
[TBL] [Abstract][Full Text] [Related]
15. The usefulness of serum angiotensin-converting enzyme test in the diagnosis of sarcoidosis.
Podwysocki B; Skowron-Szlósarczyk S; Zwoliński J; Szklarz E; Jankowska E; Masiak M
Mater Med Pol; 1991; 23(2):121-4. PubMed ID: 1668804
[TBL] [Abstract][Full Text] [Related]
16. Serum angiotensin-converting enzyme as a marker for the chronic fatigue-immune dysfunction syndrome: a comparison to serum angiotensin-converting enzyme in sarcoidosis.
Lieberman J; Bell DS
Am J Med; 1993 Oct; 95(4):407-12. PubMed ID: 8213873
[TBL] [Abstract][Full Text] [Related]
17. Role of serum angiotensin converting enzyme in sarcoidosis.
Khan AH; Ghani F; Khan A; Khan MA; Khurshid M
J Pak Med Assoc; 1998 May; 48(5):131-3. PubMed ID: 9813973
[TBL] [Abstract][Full Text] [Related]
18. [Serum level of angiotensin-converting enzyme in sarcoidosis. Attempted correlation with the clinical activity of the disease (author's transl)].
Larzul JJ; Le Treut A; Couliou H; Beaumont D; Delaval P; Sapene M; de Labarthe B
Nouv Presse Med; 1981 Feb; 10(9):675-8. PubMed ID: 6259614
[TBL] [Abstract][Full Text] [Related]
19. [Elevated negative predictive value of angiotensin converting enzyme in the diagnosis of active sarcoidosis].
Muñoz J; García Río F; de Ramón A; Martínez I; Ortega B; García Satué JL; Pino JM; Granado S; Villamor J
Rev Clin Esp; 1993 Oct; 193(5):221-4. PubMed ID: 8256006
[TBL] [Abstract][Full Text] [Related]
20. Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis.
Enyedi A; Csongrádi A; Altorjay IT; Beke GL; Váradi C; Enyedi EE; Kiss DR; Bányai E; Kalina E; Kappelmayer J; Tóth A; Papp Z; Takács I; Fagyas M
Clin Chim Acta; 2020 Jan; 500():155-162. PubMed ID: 31672631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
